HC
Hexstone Capital LLC disclosed a 7.7% stake in ACTU
Hexstone Capital LLC reported owning 7.7% of Actuate Therapeutics, Inc. (ACTU) (4,225,352 shares) in a Schedule 13G filed Oct 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 30, 2026
- Source
- Schedule 13G